Published in Intervirology on January 01, 1998
Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya. J Clin Microbiol (2000) 3.83
Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR. J Clin Microbiol (2004) 3.56
Automated quantitative analysis of hepatitis B virus DNA by using the Cobas Amplicor HBV monitor test. J Clin Microbiol (1999) 1.89
European proficiency testing program for molecular detection and quantitation of hepatitis B virus DNA. J Clin Microbiol (2001) 1.24
Quantitative molecular analysis of virus expression and replication. J Clin Microbiol (2000) 1.11
Comparative evaluation of semiautomated COBAS AMPLICOR hepatitis B virus (HBV) monitor test and manual microwell plate-based AMPLICOR HBV MONITOR test. J Clin Microbiol (2001) 1.04
Fully automated, internally controlled quantification of hepatitis B Virus DNA by real-time PCR by use of the MagNA Pure LC and LightCycler instruments. J Clin Microbiol (2004) 1.00
Monitoring Intact Viruses Using Aptamers. Biosensors (Basel) (2016) 0.94
Elevated plasma levels of 90K (Mac-2 BP) immunostimulatory glycoprotein in HIV-1-infected children. J Clin Immunol (2000) 0.90
Quality of human immunodeficiency virus viral load testing in Australia. J Clin Microbiol (2000) 0.88
Cytomegalovirus infection in the bone marrow transplant patient. World J Transplant (2015) 0.88
Molecular methods of measurement of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection: implications for occupational health practice. Occup Environ Med (1999) 0.86
LNA real-time PCR probe quantification of hepatitis B virus DNA. Exp Ther Med (2011) 0.80
Quantitative molecular virology in patient management. J Clin Pathol (2000) 0.76
Hepatitis B virus DNA stability in plasma samples under short-term storage at 42°C. Braz J Med Biol Res (2015) 0.75
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet (1998) 15.09
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet (1996) 6.43
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst (1998) 6.06
A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. JAMA (1995) 4.45
Assessing the risk of breast cancer. N Engl J Med (2000) 3.72
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group. Lancet (2000) 3.50
Prevalence of antibodies to human herpesviruses and hepatitis B virus in patients at different stages of human immunodeficiency virus (HIV) infection. Infection (1991) 3.29
Treatment of SARS with human interferons. Lancet (2003) 3.10
Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med (1996) 3.07
Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am J Hum Genet (1996) 2.97
Social comparison affects reward-related brain activity in the human ventral striatum. Science (2007) 2.87
Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation. J Clin Oncol (1993) 2.79
Mosaic genes and mosaic chromosomes: intra- and interspecies genomic variation of Streptococcus pneumoniae. Infect Immun (2001) 2.75
Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol (1998) 2.55
Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2. Lancet (1999) 2.36
Reduction of the diagnostic window with a new combined p24 antigen and human immunodeficiency virus antibody screening assay. J Virol Methods (1998) 2.31
Reduction of diagnostic window by new fourth-generation human immunodeficiency virus screening assays. J Clin Microbiol (1998) 2.25
Herpes zoster guideline of the German Dermatology Society (DDG). J Clin Virol (2003) 2.22
PET with 18fluorodeoxyglucose and hexamethylpropylene amine oxime SPECT in late whiplash syndrome. Neurology (1998) 2.17
Single dose kinetics of mefloquine in man. Plasma levels of the unchanged drug and of one of its metabolites. Chemotherapy (1982) 2.06
Human hippocampus establishes associations in memory. Hippocampus (1997) 2.03
The CREATE project: development of certified reference materials for allergenic products and validation of methods for their quantification. Allergy (2008) 1.96
Non-random association between alleles detected at D4S95 and D4S98 and the Huntington's disease gene. J Med Genet (1989) 1.95
Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet (2003) 1.88
Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study. Lancet (2001) 1.87
Primary cytomegalovirus infection in an outpatient setting--laboratory markers and clinical aspects. Infection (2003) 1.78
Role for ATM in DNA damage-induced phosphorylation of BRCA1. Cancer Res (2000) 1.76
Solid-phase enzyme immunoassay for immunoglobulin M antibodies to cytomegalovirus. J Clin Microbiol (1977) 1.75
Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study. Ann Oncol (2005) 1.67
Mammographically detected breast cancer. Benefits of stereotactic core versus wire localization biopsy. Ann Surg (1996) 1.66
Human hippocampus associates information in memory. Proc Natl Acad Sci U S A (1999) 1.62
Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study. Am J Hum Genet (1998) 1.61
Detection of primary HIV infection by a second-generation HIV(p24) antigen test. Infusionsther Transfusionsmed (1994) 1.59
Studies of the RB1 gene and the p53 gene in human osteosarcomas. Pediatr Hematol Oncol (1992) 1.57
Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells. Cell Death Dis (2011) 1.51
Cetuximab, topotecan and cisplatin for the treatment of advanced cervical cancer: A phase II GINECO trial. Gynecol Oncol (2009) 1.50
[S3-guidelines--sedation in gastrointestinal endoscopy]. Z Gastroenterol (2008) 1.47
Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls. J Clin Endocrinol Metab (1997) 1.44
Second-line chemotherapy with pegylated liposomal doxorubicin and carboplatin is highly effective in patients with advanced ovarian cancer in late relapse: a GINECO phase II trial. Ann Oncol (2006) 1.44
Hepatitis delta: on soft paws across Germany. Infection (2012) 1.43
Factors associated with decisions about clinical BRCA1/2 testing. Cancer Epidemiol Biomarkers Prev (2000) 1.43
Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations-relevance for the incidence of genital herpes. J Med Virol (2000) 1.39
How accurate is serologic testing of plasma pools for hepatitis B virus surface antigen, anti-human immunodeficiency virus 1 and 2, and anti-hepatitis C virus? Infusionsther Transfusionsmed (1996) 1.39
IgM antibodies to cytomegalovirus during pregnancy. Arch Virol (1977) 1.38
Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans? Med Microbiol Immunol (2010) 1.36
Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine. J Pharmacol Exp Ther (1988) 1.35
Diaphragm disease of the ascending colon. Association with sustained-release diclofenac. J Clin Gastroenterol (1993) 1.34
Pre-operative systemic (neo-adjuvant) therapy with trastuzumab and docetaxel for HER2-overexpressing stage II or III breast cancer: results of a multicenter phase II trial. Ann Oncol (2005) 1.33
The BDNF Val66Met polymorphism impacts parahippocampal and amygdala volume in healthy humans: incremental support for a genetic risk factor for depression. Psychol Med (2009) 1.33
Atomic-scale, all epitaxial in-plane gated donor quantum dot in silicon. Nano Lett (2009) 1.30
An influenza A H1N1 virus revival - pandemic H1N1/09 virus. Infection (2009) 1.30
Updated European recommendations for the clinical use of HIV drug resistance testing. Antivir Ther (2004) 1.28
The assessment of hemispheric lateralization in functional MRI--robustness and reproducibility. Neuroimage (2006) 1.27
Nine breast angiosarcomas after conservative treatment for breast carcinoma: a survey from French comprehensive Cancer Centers. Int J Radiat Oncol Biol Phys (1999) 1.25
Hepatitis B virus markers in anti-HBc only positive individuals. J Med Virol (2001) 1.23
Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives. Pharmacogenetics (2001) 1.23
Cimetidine for pruritus in Hodgkin's disease. Br Med J (1980) 1.23
Vitamin D in schizophrenia, major depression and alcoholism. J Neural Transm (Vienna) (2000) 1.23
With aging in humans the activity of the hypothalamus-pituitary-adrenal system increases and its diurnal amplitude flattens. Life Sci (1997) 1.22
Cross-reactivity in flavivirus serology: new implications of an old finding? Med Microbiol Immunol (2002) 1.21
Molecular typing of Treponema pallidum strains from patients with neurosyphilis in Pretoria, South Africa. Sex Transm Infect (2007) 1.21
Evaluation of 11 enzyme immunoassays for the detection of immunoglobulin M antibodies to Epstein-Barr virus. J Virol Methods (1996) 1.20
Sensitive and selective determination of picogram amounts of ciprofloxacin and its metabolites in biological samples using high-performance liquid chromatography and photothermal post-column derivatization. J Chromatogr (1987) 1.19
Prolonged Th2 cell activation and increased viral replication in HIV-Leishmania co-infected patients despite treatment. Trans R Soc Trop Med Hyg (1996) 1.19
Human cytomegalovirus replicates in primary human bone marrow cells. J Gen Virol (1986) 1.18
Expression of hypoxia-inducible genes in tumor cells. J Cancer Res Clin Oncol (1998) 1.18
Privacy in genetics research. Science (1999) 1.17
Hsp90 phosphorylation is linked to its chaperoning function. Assembly of the reovirus cell attachment protein. J Biol Chem (2001) 1.17
Dynamic laser speckle imaging of cerebral blood flow. Opt Express (2009) 1.17
Pulmonary function in asymptomatic adolescents with idiopathic scoliosis. Am Rev Respir Dis (1975) 1.15
Iodine in contrast agents and skin disinfectants is the major cause for hypothyroidism in premature infants during intensive care. Horm Res (1987) 1.15
Evaluation of the reliability of 6 current anti-HIV-1/HIV-2 enzyme immunoassays. J Virol Methods (1995) 1.14
Identification of tumor-associated MHC class I ligands by a novel T cell-independent approach. Eur J Immunol (2000) 1.13
Influenza vaccination compliance among health care workers in a German university hospital. Infection (2008) 1.13
Risk factors for the development of retinopathy in children and adolescents with type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1986) 1.13
A study of human reovirus IgG and IgA antibodies by ELISA and western blot. J Virol Methods (1994) 1.12
Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives. Clin Exp Allergy (2008) 1.12
Effects of major depression, aging and gender upon calculated diurnal free plasma cortisol concentrations: a re-evaluation study. Stress (1998) 1.11
Lumbar bone mineral density in patients with major depression: evidence of increased bone loss at follow-up. Am J Psychiatry (2000) 1.11
Risk modifiers in carriers of BRCA1 mutations. Int J Cancer (1995) 1.10
Low correlation of human cytomegalovirus DNA amplification by polymerase chain reaction with cytomegalovirus disease in organ transplant recipients. J Med Virol (1994) 1.10
Quantitation of the major fungal allergens, Alt a 1 and Asp f 1, in commercial allergenic products. J Allergy Clin Immunol (2001) 1.09
Evaluation of diagnostic methods for the detection of cytomegalovirus in recipients of allogeneic stem cell transplants. J Clin Virol (2001) 1.09
Stability and inactivation of SARS coronavirus. Med Microbiol Immunol (2005) 1.09
The role of viral load determination for the management of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection. J Clin Virol (2001) 1.08
Nonrandom association between Huntington disease and two loci separated by about 3 Mb on 4p16.3. Genomics (1992) 1.07
Endoscopic features of Helicobacter pylori-related gastritis. Endoscopy (1995) 1.07
Viral zoonoses - a threat under control? Intervirology (2003) 1.07
Rapid diagnosis of enterovirus infection by a new one-step reverse transcription-PCR assay. J Clin Microbiol (1997) 1.06
Plasma leptin in depressed patients and healthy controls. Horm Metab Res (1996) 1.06
Characterization of a hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapy. Int Arch Allergy Immunol (2007) 1.05
Differential expression of genes encoding tight junction proteins in colorectal cancer: frequent dysregulation of claudin-1, -8 and -12. Int J Colorectal Dis (2006) 1.05